Back to Agenda
Session 7 Plenary Session: International Update
Session Chair(s)
Louise Déry
Director, Policy, Planning and International Affairs Directorate
Health Canada, Canada
In this session, we will reflect on some of the gains made in Canada, with respect to advancement in clinical research investment, and will discuss future opportunities to make Canada more competitive in the areas of research, investment, and innovation within the international arena.
A representative from Health Canada will also discuss Canada’s involvement with ICH, highlighting new updates, governance, guidance, and future projects.
The meeting will close with remarks from the Deputy Minister of Health at Health Canada.
Speaker(s)
Advancement in Clinical Research Investment and Future Innovation in Canada
Ed Dybka
Astrazeneca Canada, Inc., Canada
President
ICH Updates
Celia Lourenco, PhD
Health Canada, Canada
Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB
Update from the Australian Therapeutic Goods Administration (TGA)
Diane Wilkinson
Australian Therapeutic Goods Administration (TGA), Australia
Asst Dir, Regulatory Reform and Coordination Section, Complementary Medicines Br
Closing Remarks
Simon Kennedy, MS
Health Canada, Canada
Deputy Minister of Health
Have an account?